Cohort information
| Min | Max | Median | |||
| Age at diagnosis (years) | 38 | 89 | 64 | ||
| Time to relapse (years) | 0.5 | 13.9 | 1.7 | ||
| Sex | |||||
| Male | Female | ||||
| 17 | 21 | ||||
| Cell of Origin | |||||
| (Avaliable for 35 cases) | Relapse | ||||
| ABC | GCB | UNC | |||
| Diagnosis | ABC | 17 | 1 | 2 | |
| GCB | 0 | 11 | 1 | ||
| UNC | 1 | 0 | 2 | ||
| Site of Biopsy | |||||
| Relapse | |||||
| Nodal | Extranodal | ||||
| Diagnosis | Nodal | 8 | 7 | ||
| Extranodal | 11 | 12 | |||
| Treatment | |||||
| Treatment | Frequency | ||||
| R-CHOP | 30 | ||||
| R-CHOP + IT MTX | 3 | ||||
| R-CHOP + LOCALISED RT | 1 | ||||
| R-CHOP X3 + IT MTX AND IFRT | 1 | ||||
| R-CHOP X3 + RADIOTHERAPY | 1 | ||||
| R-CEOP | 1 | ||||
| R-CEOP + RADIOTHERAPY | 1 | ||||
| Min | Max | Median | |||
| Age at diagnosis (years) | 38 | 89 | 64 | ||
| Time to relapse (years) | 0.5 | 13.9 | 1.7 | ||
| Sex | |||||
| Male | Female | ||||
| 17 | 21 | ||||
| Cell of Origin | |||||
| (Avaliable for 35 cases) | Relapse | ||||
| ABC | GCB | UNC | |||
| Diagnosis | ABC | 17 | 1 | 2 | |
| GCB | 0 | 11 | 1 | ||
| UNC | 1 | 0 | 2 | ||
| Site of Biopsy | |||||
| Relapse | |||||
| Nodal | Extranodal | ||||
| Diagnosis | Nodal | 8 | 7 | ||
| Extranodal | 11 | 12 | |||
| Treatment | |||||
| Treatment | Frequency | ||||
| R-CHOP | 30 | ||||
| R-CHOP + IT MTX | 3 | ||||
| R-CHOP + LOCALISED RT | 1 | ||||
| R-CHOP X3 + IT MTX AND IFRT | 1 | ||||
| R-CHOP X3 + RADIOTHERAPY | 1 | ||||
| R-CEOP | 1 | ||||
| R-CEOP + RADIOTHERAPY | 1 | ||||